Neuraxial blocks and anticoagulants (ASRA)
Stem
A 72-year-old woman, 70 kg, is scheduled for total knee replacement. She stopped clopidogrel 7 days ago as instructed and also takes aspirin and naproxen. Creatinine clearance is 45 mL/min. The surgeon plans enoxaparin 30 mg twice daily starting the morning after surgery and asks you to leave an epidural catheter in for 48 hours of analgesia.
Question
Can you place a neuraxial block, and how will you manage a catheter around this anticoagulation plan?
Ideal answer
HeadlineYes to the block: clopidogrel is past its interval, and aspirin and NSAIDs alone change no timing. No to a 48-hour catheter with twice-daily enoxaparin.
- Drug, dose, timing, kidneys first: ASRA's fifth edition (2025)1 classes drugs as low or high dose and ties intervals to creatinine clearance.2 Clopidogrel: 5–7 days.3
- Twice-daily LMWH: catheter out before the first dose, which comes the next day, at least 12 hours after placement and 4 hours after removal.3
- No aspirin or naproxen alongside catheter plus LMWH, as ASRA advises against other hemostasis-altering drugs.3
- Alternatives for the surgeon: spinal plus a peripheral block; a catheter removed before the first dose; or once-daily low-dose enoxaparin, which lets a catheter stay, out 12 hours after a dose.3
- Neurologic checks after every placement or removal, since hematomas decompressed within 8 hours do much better.4
Breaking down the answer
- Judgment, not just memory — the examiner weighs a rare, catastrophic hematoma against neuraxial benefit, and my coordination with surgeons and medicine teams. Changes if: the interval is not met; I choose a different technique rather than compromise.
- Trough timing for DOACs — pulling is as risky as the needle. Restart after needle or catheter: low-dose DOAC at least 6 hours later, high-dose at least 24 hours.3
- Core intervals — LMWH low dose 12 hours, high dose 24 hours; warfarin stopped 5 days with a normal INR; high-dose apixaban, rivaroxaban and edoxaban 72 hours; low-dose apixaban 36 hours, low-dose rivaroxaban 24 hours; prasugrel 7–10 days, ticagrelor 5 days.3
- Dabigatran and kidneys — high dose 72 hours at clearance ≥50 mL/min, 120 hours at 30–49, and no neuraxial or deep block below 30; low dose 48 hours. Low-dose rivaroxaban: 30 hours below 30 mL/min.3
- Subcutaneous heparin — 5000 units two or three times daily needs 4–6 hours or normal coagulation status; 7500–10,000 units twice daily (up to 20,000 units a day) needs 12 hours and normal coagulation; larger doses 24 hours.3
- IV heparin — I wait at least 1 hour after needle placement before intraoperative IV heparin; an infusion stops 4–6 hours before a block. Changes if: a bloody tap prompts discussion, not mandatory cancellation.3
- Deep blocks follow neuraxial rules — lumbar plexus and other deep, non-compressible blocks take the same intervals; superficial blocks are judged on compressibility and vascularity.3
Follow-up question
The catheter was left in and twice-daily enoxaparin started as planned. On postoperative day 2, six hours after the catheter is pulled, she develops new bilateral leg weakness and back pain. What do you do?
Follow-up answer
HeadlineEpidural hematoma until proven otherwise; I stop all anticoagulants and tell the team exactly that.
I examine her and order an emergency MRI and call neurosurgery at the same time, not sequentially, because recovery is far more likely with laminectomy within 8 hours of the onset of deficits.4 Coagulation studies, platelets, reversal planned with hematology, and her neurologic exam reassessed while we wait. I disclose to her, document every dose time, and review the violation: with twice-daily low-dose LMWH the catheter should have been removed before the first dose, with the dose delayed 4 hours after removal.3
Pitfalls that cost points
- Quoting one 72-hour interval for every DOAC without asking the dose and the renal function.
- Proceeding on a "borderline" interval when a peripheral block or IV technique would do.
- Blaming new weakness on the local anesthetic without stopping the infusion and checking for recovery within 2 hours.
Rapid-fire
Q: Why are NSAIDs alone acceptable? A: NSAIDs, including aspirin, do not add measurable risk of major bleeding, so ASRA sets no specific timing for blocks or catheter removal.3
Q: What INR is acceptable for catheter removal on warfarin? A: Below 1.5. If warfarin began preoperatively, I check INR before placement when the first dose was over 24 hours earlier or a second was given; neurologic checks continue 48 hours after removal.3
Q: Why the longer wait for high-dose LMWH? A: Anti-Xa activity persists after higher doses, especially in elderly and renal impairment. At her clearance of 45 the low-dose intervals stand; ASRA advises against routine anti-Xa monitoring; it does not predict bleeding.3
Q: Why can a patient on aspirin for a stent have a spinal? A: Aspirin alone does not prohibit neuraxial blocks; stopping it risks stent thrombosis.
Numbers to know
| Item | Value |
|---|---|
| LMWH low dose / high dose | 12 h / 24 h before placement3 |
| Next LMWH dose after removal | ≥4 h3 |
| Apixaban, rivaroxaban, edoxaban (high dose) | 72 h; first dose ≥24 h after placement or removal3 |
| Apixaban / rivaroxaban (low dose) | 36 h / 24 h; first dose ≥6 h after placement or removal3 |
| Dabigatran | High dose 72 h (CrCl ≥50) or 120 h (CrCl 30–49); low dose 48 h3 |
| Clopidogrel / prasugrel / ticagrelor | 5–7 d / 7–10 d / 5 d3 |
| Warfarin | Stop 5 d, normal INR; remove catheter at INR <1.53 |
| Hematoma decompression | Within 8 h of symptoms4 |
Links
- Epidural hematoma and abscess, Regional anesthesia in the anticoagulated patient with pre-existing neuropathy, Anticoagulation, thrombocytopenia and neuraxial blocks, Recent MI, coronary stents and antiplatelet therapy, Thoracic epidural analgesia
- ASRA evidence-based guidelines on regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy (fifth edition, 2025); SOAP consensus on the anticoagulated obstetric patient
Sources
- 1.Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: ASRA Pain Medicine Evidence-Based Guidelines (fifth edition) · ASRA Pain Medicine, 2025 · asra.comASRA landing page for Kopp SL, Vandermeulen E, McBane RD, et al. Reg Anesth Pain Med 2025 (rapm-2024-105766); full text at rapm.bmj.com could not be fetched.
- 2.Block and Load: The ASRA's Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy - 5th edition · ESRA, 2025 · esraeurope.orgDescribes the move from prophylactic/therapeutic to low-dose/high-dose terminology and renal-function-based timelines.
- 3.ASRA Guidelines for Regional Anesthesia with Antithrombotic or Thrombolytic Therapy 5th Edition - Summary of Recommendations · Guideline Central / ASRA Pain Medicine, 2025 · guidelinecentral.comVerbatim recommendation list of the fifth edition, produced in participation with ASRA; source of every interval on this page.
- 4.Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: ASRA Evidence-Based Guidelines (Fourth Edition) · ASRA, 2018 · history.mayoclinic.orgCited only for the spinal hematoma outcome data (laminectomy within 8 hours of onset); intervals on this page follow the fifth edition.
Facts on this page were checked against these sources on Oct 14, 2026. Guidelines change; confirm doses against current institutional protocols.